The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.

Revenue
+14.5%
EPS
+23.6%
Free cash flow
+89.2%
Total debt
+39.2%

Quarter to September 2026, against a year earlier

181.95 6.36 −3.38%
Market cap
$10.6B
P/E
26.3×
Fwd P/E
25.4×
Dividend yield
0.14%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100

The Ensign Group, Inc. (ENSG) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, The Ensign Group, Inc. (ENSG) trades at a EV/Sales of 1.8×. Over the past ten years it has ranged from 0.6× (November 2016) to 2.4× (March 2026); the current reading is higher than 84% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.9× 12.60%
FY2024 1.7× 4.09%
FY2023 1.6× (2.66%)
FY2022 1.7× (2.37%)
FY2021 1.7× 8.30%
FY2020 1.6× 19.15%
FY2019 1.3× 11.12%
FY2018 1.2× 39.13%
FY2017 0.9× 11.30%
FY2016 0.8× (8.60%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.7× 3.52%
Jun 2026 1.7× (21.72%)
Mar 2026 2.1× 12.31%
Dec 2025 1.9× (4.50%)
43 more quarters

Against its own ten years

Low 0.6× High 2.4×
Ten-year median 1.5×
Current reading's percentile 82

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ENSG